Veracyte, Inc. SEC filings VCYT

Veracyte, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jul 2, 2015. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, other events). The company's fiscal year ends on December 31.

Veracyte, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Other events
Nov 4, 2026 Nov 4, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Sep 14, 2026 Sep 10, 2026
10-Q Quarterly report Jul 31, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2026 Jun 10, 2026
S-8 Employee stock plan registration Jun 10, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 10, 2026
8-K Current report
Officer or director change
Mar 16, 2026 Mar 13, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 11, 2026
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2025 Jun 17, 2025
S-8 Employee stock plan registration Jun 17, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 17, 2025
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 24, 2025 Feb 24, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Officer or director change
Sep 4, 2024 Sep 3, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2024 Jun 12, 2024
UPLOAD Letter from the SEC Jun 13, 2024 —
S-8 Employee stock plan registration Jun 12, 2024 —
CORRESP Letter to the SEC Jun 7, 2024 —
UPLOAD Letter from the SEC May 28, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 12, 2024
8-K/A Amended current report Apr 17, 2024 Feb 5, 2024
8-K Current report
Other events
Mar 22, 2024 Mar 22, 2024
424B7 Filing Mar 22, 2024 —
8-K Current report
Other events
Feb 29, 2024 Feb 29, 2024
424B7 Filing Feb 29, 2024 —
S-8 Employee stock plan registration Feb 29, 2024 —
S-3ASR Automatic shelf registration Feb 29, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 22, 2024 Feb 22, 2024
8-K Current report
Officer or director change
Feb 13, 2024 Feb 7, 2024
8-K Current report
Acquisition or sale of assets, Unregistered share sale
Feb 6, 2024 Feb 5, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations, Officer or director change
Aug 8, 2023 Aug 4, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 9, 2023 Jun 8, 2023
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
S-8 POS Filing Jun 8, 2023 —
DEFA14A Additional proxy material Jun 1, 2023 —
10-Q Quarterly report May 5, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 —
PRE 14A Preliminary proxy statement Apr 17, 2023 —
S-8 Employee stock plan registration Mar 1, 2023 —
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 22, 2023 Feb 22, 2023
8-K Current report
Bylaw or fiscal year change
Feb 10, 2023 Feb 9, 2023
8-K Current report
Officer or director change
Dec 14, 2022 Dec 9, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
8-K Current report
Officer or director change
Aug 11, 2022 Aug 9, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 2, 2022 Aug 2, 2022
8-K Current report
Shareholder vote results
Jun 16, 2022 Jun 15, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 3, 2022 May 3, 2022
DEFA14A Additional proxy material Apr 26, 2022 —
DEF 14A Proxy statement Apr 26, 2022 Jun 15, 2022
S-8 Employee stock plan registration Mar 1, 2022 —
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Officer or director change
Feb 22, 2022 Feb 19, 2022
8-K Current report
Officer or director change
Jan 11, 2022 Jan 6, 2022
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
UPLOAD Letter from the SEC Sep 20, 2021 —
CORRESP Letter to the SEC Sep 9, 2021 —
UPLOAD Letter from the SEC Aug 27, 2021 —
8-K Current report
Other events
Aug 4, 2021 Aug 4, 2021
424B7 Filing Aug 4, 2021 —
8-K Current report
Acquisition or sale of assets, Unregistered share sale
Aug 3, 2021 Aug 2, 2021
10-Q Quarterly report Jul 29, 2021 Jun 30, 2021
8-K Current report
Results of operations
Jul 29, 2021 Jul 29, 2021
8-K Current report
Officer or director change
Jul 16, 2021 Jul 13, 2021
8-K Current report
Material agreement, Unregistered share sale
Jul 13, 2021 Jul 13, 2021
8-K Current report
Officer or director change
Jul 12, 2021 Jul 12, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 8, 2021 Jun 7, 2021
8-K/A Amended current report
Material agreement
Jun 8, 2021 Jun 1, 2021
425 Filing Jun 1, 2021 —
8-K Current report
Material agreement
Jun 1, 2021 Jun 1, 2021
8-K Current report
Other events
May 19, 2021 May 19, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations, Officer or director change
May 10, 2021 May 7, 2021
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 7, 2021
8-K Current report
Results of operations, Officer or director change
Apr 15, 2021 Apr 12, 2021
8-K Current report
Officer or director change
Apr 5, 2021 Apr 1, 2021
8-K Current report
Officer or director change
Mar 22, 2021 Mar 19, 2021
8-K Current report
Acquisition or sale of assets
Mar 15, 2021 Mar 12, 2021
8-K Current report
Officer or director change
Mar 3, 2021 Feb 26, 2021
S-8 Employee stock plan registration Feb 22, 2021 —
10-K Annual report Feb 22, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 17, 2021 Feb 17, 2021
424B5 Prospectus supplement Feb 5, 2021 —
8-K Current report
Other events
Feb 5, 2021 Feb 4, 2021
425 Filing Feb 3, 2021 —
425 Filing Feb 3, 2021 —
425 Filing Feb 3, 2021 —
425 Filing Feb 3, 2021 —
424B5 Prospectus supplement Feb 3, 2021 —
S-3ASR Automatic shelf registration Feb 3, 2021 —
425 Filing Feb 3, 2021 —
8-K Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure
Feb 3, 2021 Feb 2, 2021
8-K Current report
Bylaw or fiscal year change
Jan 25, 2021 Jan 22, 2021
8-K Current report
Other events
Dec 16, 2020 Dec 16, 2020
8-K Current report
Officer or director change
Nov 17, 2020 Nov 17, 2020
10-Q Quarterly report Nov 2, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 2, 2020 Nov 2, 2020
8-K Current report
Other events
Aug 5, 2020 Aug 4, 2020
424B5 Prospectus supplement Aug 5, 2020 —
424B5 Prospectus supplement Aug 3, 2020 —
S-8 Employee stock plan registration Jul 31, 2020 —
10-Q Quarterly report Jul 30, 2020 Jun 30, 2020
8-K Current report
Results of operations
Jul 30, 2020 Jul 30, 2020
8-K Current report
Officer or director change
Jul 27, 2020 Jul 22, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 9, 2020 Jun 5, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
DEFA14A Additional proxy material Apr 24, 2020 —
DEF 14A Proxy statement Apr 24, 2020 Apr 24, 2020
8-K Current report
Results of operations
Apr 16, 2020 Apr 16, 2020
8-K Current report
Bylaw or fiscal year change
Apr 14, 2020 Apr 13, 2020
8-K Current report
Officer or director change
Mar 2, 2020 Mar 2, 2020
8-K Current report
Other events
Feb 25, 2020 Feb 25, 2020
424B7 Filing Feb 25, 2020 —
S-8 Employee stock plan registration Feb 25, 2020 —
10-K Annual report Feb 25, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 25, 2020 Feb 25, 2020
SEC STAFF LETTER Filing Feb 20, 2020 —
8-K/A Amended current report Feb 18, 2020 Dec 3, 2019
SEC STAFF LETTER Filing Feb 10, 2020 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
Dec 3, 2019 Dec 3, 2019
10-Q Quarterly report Oct 22, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 22, 2019 Oct 22, 2019
10-Q Quarterly report Jul 30, 2019 Jun 30, 2019
8-K Current report
Results of operations
Jul 30, 2019 Jul 30, 2019
8-K Current report
Officer or director change
Jun 28, 2019 Jun 28, 2019
8-K/A Amended current report
Shareholder vote results
Jun 13, 2019 Jun 11, 2019
8-K Current report
Shareholder vote results
Jun 11, 2019 Jun 11, 2019
SEC STAFF LETTER Filing Jun 4, 2019 —
SEC STAFF LETTER Filing May 24, 2019 —
8-K Current report
Material agreement, Other events
May 3, 2019 May 2, 2019
424B5 Prospectus supplement May 3, 2019 —
424B5 Prospectus supplement May 2, 2019 —
S-3ASR Automatic shelf registration May 2, 2019 —
RW Filing May 2, 2019 —
424B5 Prospectus supplement May 1, 2019 —
S-3 Shelf registration May 1, 2019 —
10-Q Quarterly report Apr 30, 2019 Mar 31, 2019
8-K Current report
Results of operations
Apr 30, 2019 Apr 30, 2019
8-K Current report
Officer or director change
Apr 26, 2019 Apr 26, 2019
DEFA14A Additional proxy material Apr 24, 2019 —
DEF 14A Proxy statement Apr 24, 2019 Apr 24, 2019
CT ORDER Filing Mar 11, 2019 —
8-K Current report
Officer or director change
Feb 26, 2019 Feb 26, 2019
S-8 Employee stock plan registration Feb 25, 2019 —
10-K Annual report Feb 25, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 25, 2019 Feb 25, 2019
8-K Current report
Material agreement
Jan 3, 2019 Jan 3, 2019
10-Q Quarterly report Oct 29, 2018 Sep 30, 2018
8-K Current report
Results of operations
Oct 29, 2018 Oct 29, 2018
8-K Current report
Officer or director change
Oct 26, 2018 Oct 26, 2018
8-K Current report
Material agreement, Other events
Jul 26, 2018 Jul 25, 2018
424B5 Prospectus supplement Jul 26, 2018 —
424B3 Prospectus Jul 24, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
VCYT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1384101
Former names
CALDEROME INC (until Feb 27, 2008)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.